Atlas Trials

A Study of Bumetanide for the Treatment of Autism Spectrum Disorders

Clinical trial NCT03156153 · COMPLETED

Trial details

NCT number
NCT03156153
Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Autism Spectrum Disorder
Start date
2017-05-24
Primary completion
2019-07-08
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.